Raphael Borie | Gene Regulation Epigenetics | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Raphael Borie | Gene Regulation Epigenetics | Best Researcher Award

Prof. Dr. Raphael Borie, APHP, France

Dr. Raphaël Borie, born on August 15, 1977, in Paris, France, is a leading expert in pulmonology and genetic respiratory diseases. Currently a University Professor Hospital Practitioner at Bichat Hospital (Paris Cité University), he has consistently contributed to the advancement of respiratory medicine, particularly in the field of interstitial lung diseases (ILDs). His clinical insight, combined with a strong research portfolio, has positioned him as a prominent figure within the OrphaLung network. A dedicated family man with two children, Dr. Borie is widely respected for his integrity, leadership, and commitment to collaborative medicine. His career reflects a unique blend of academic excellence and impactful translational research, bridging the gap between genomics and clinical care in ILD. He is a registered member of the French Medical Council (Ordre des Médecins No. 75/71138), and his research has influenced European clinical guidelines and improved the understanding of rare genetic pulmonary conditions.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Robust Academic Background:
    Dr. Borie holds a PhD in Genetics, Master’s in Physiology, and HDR (habilitation to supervise doctoral research), which underlines his scientific credibility and ability to lead independent research.

  2. Clinical-Research Integration:
    As a University Professor and Hospital Practitioner, he merges frontline patient care with cutting-edge genetic and respiratory disease research.

  3. High Publication Impact:
    With 283 PubMed-indexed articles and an H-index of 60, Dr. Borie’s work demonstrates strong citation influence, indicating widespread recognition and utility in the scientific community.

  4. International Leadership:
    Active in multinational collaborations (e.g., OrphaLung, ERS), he has co-authored major position statements and clinical trials, influencing European respiratory care guidelines.

  5. Innovation in Rare Diseases:
    A recognized expert in familial interstitial lung disease and telomere disorders, his work has led to earlier diagnosis and targeted therapies—critical in fields where few experts exist.

  6. Recognition and Funding:
    He has secured prestigious mobility grants (ERS, Respirology Teachers College)—a marker of trust in his scientific mission and innovation.

🔍 Areas for Improvement:

  • Wider Public Health Translation: While Dr. Borie’s genomic research is exceptional, expanding into real-world health policy implementation could enhance systemic impact.

  • Patient Engagement & Advocacy: Developing patient-oriented tools or registries (e.g., digital apps or platforms for familial lung diseases) may broaden his outreach beyond academia and clinics.

  • Broader Visibility: Although highly cited in professional circles, participation in international keynote talks, editorial leadership, or mainstream health media could elevate his public and professional visibility.

🎓 Education:

Dr. Borie has pursued an extensive and rigorous academic path focused on respiratory and genetic medicine. He obtained his medical degree with specialization in Allergology and Immunopathology in 2006. A year earlier, in 2005, he earned a Master’s degree in Biology and Physiology of Circulation and Respiration. Demonstrating deep interest in genetics, he completed a PhD in Genetics in 2017, contributing significantly to our understanding of genetic underpinnings in pulmonary fibrosis. In 2019, Dr. Borie achieved the prestigious Habilitation à Diriger des Recherches (HDR) from the University of Paris 7, enabling him to supervise doctoral research. His academic background illustrates a powerful integration of clinical expertise and molecular research—providing him with the tools to lead innovative research projects at the intersection of genomics and pulmonology.

🩺 Experience:

Dr. Raphaël Borie has over 15 years of experience in respiratory medicine. From July 2011 to August 2020, he served as a Hospital Practitioner in the Pneumology Department at Bichat Hospital under Professors Aubier and Crestani. Since September 2020, he has been a University Professor Hospital Practitioner in the same department, affiliated with Paris Cité University. He has contributed to patient care, education of medical students and residents, and cutting-edge research. As part of the OrphaLung network, he plays a critical role in advancing diagnostic tools and treatment approaches for rare lung diseases. He is recognized for his collaborative leadership and interdisciplinary contributions across genetics, immunology, and pulmonology. His international collaborations and authorship of over 280 PubMed-indexed publications demonstrate his ongoing commitment to improving patient outcomes through translational research.

🏆 Awards and Honors:

Dr. Borie’s research excellence has been recognized through several prestigious awards and scholarships. In 2017, he received the European Respiratory Society (ERS) Mobility Grant for his work on Identification of Preclinical Markers of Pulmonary Fibrosis, supporting international collaboration and advanced training. The same year, he was also honored with the Respirology Teachers College Mobility Grant, reinforcing his pioneering research on early detection of fibrotic lung disease. His selection for these awards highlights both scientific innovation and dedication to knowledge exchange. His leadership in multi-center studies and involvement in ERS guideline statements further reflect his status as a thought leader in interstitial lung disease. These honors are a testament to his influence in shaping the future of pulmonary genetics and translational respiratory medicine.

🔬 Research Focus:

Dr. Raphaël Borie’s research centers on familial and genetic interstitial lung diseases, particularly the molecular mechanisms behind pulmonary fibrosis, telomere biology, surfactant-related gene variants, and early detection strategies. He works extensively on identifying genetic risk variants (e.g., MUC5B, DSP) and their implications in idiopathic pulmonary fibrosis. Through his participation in the OrphaLung network, he supports genomic screening for hereditary lung disorders and contributes to developing European guidelines. His work bridges genomic medicine and clinical pulmonology, aiming for earlier diagnosis and personalized treatment approaches. He has led and co-authored critical studies on RTEL1 mutations, telomerase complex defects, and familial ILD phenotypes, helping clinicians globally understand the heterogeneity and systemic implications of genetic lung disorders. His collaborative international research ensures his findings are applied in practice to optimize long-term patient care.

📚Publications Top Notes:

  • 🧬 High risk of lung cancer in surfactant-related gene variant carriers – Eur Respir J, 2024

  • 📄 European Respiratory Society Statement on Familial Pulmonary Fibrosis – Eur Respir J, 2022

  • 🧪 Colocalization of Gene Expression and DNA Methylation with Genetic Risk Variants – Am J Respir Crit Care Med, 2022

  • 🧬 RTEL1 mutations and their phenotypic variability – Eur Respir J, 2019

  • 💊 Safety and efficacy of pirfenidone in telomerase mutation carriers – Eur Respir J, 2018

  • 🌐 Diagnosis and follow-up of familial ILD: International survey – BMC Pulmonary Med, 2025

  • 🧬 New 2023 ACR/EULAR APS criteria performance in young patients – Letter, 2025

  • 🫁 A non-resolving cough: a case of familial pulmonary fibrosis – Breathe, 2025

  • 🧬 PFMG2025: Genomic medicine in French healthcare system – Review, 2025

  • 💊 Efficacy of CFTR modulators in ABCA3-deficiency ILD – Open Access, 2025

  • 🧠 Neurological manifestations in VEXAS syndrome – Journal of Neurology, 2025

  • 💉 Real-life use of PEXIVAS reduced-dose regimen in vasculitis – Ann Rheum Dis, 2025

  • 🧫 Recurrent respiratory papillomatosis with lung involvement – Eur Respir J, 2025

  • 🔍 RA-ILD: genetics to clinical overview – Review, 2025

  • 👶 Childhood ILD survivors in adulthood: European study – Eur Respir J, 2025

🧾 Conclusion:

Dr. Raphaël Borie exemplifies the ideal candidate for the Best Researcher Award. His excellence spans across clinical expertise, academic distinction, and international research leadership, especially in genetic and familial interstitial lung diseases—a field with enormous unmet need. His consistent scholarly output, impactful collaborations, and patient-focused studies highlight a unique blend of depth and innovation. While further expansion into public health frameworks and patient engagement tools would be valuable, his profile already reflects a world-class researcher with transformative contributions to pulmonary medicine.

Yang Liu | Cell Migration Studies | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Yang Liu | Cell Migration Studies | Best Researcher Award

Prof. Dr. Yang Liu, Taiyuan University of Technology Institute of Biomedical Engineering CHINA, China

Dr. Yang Liu is an Associate Professor at the Institute of Biomedical Engineering, Taiyuan University of Technology, China. Since joining in 2013, Dr. Liu has focused on biomechanics, particularly the mechanical mechanisms involved in skin tissue damage and healing processes during traumatic events like burns and radiotherapy. Her interdisciplinary work bridges molecular, cellular, and tissue-level studies to better understand the interplay between mechanical factors and skin regeneration. Her research also extends into the development and structural optimization of biomedical materials such as tissue-engineered skins and advanced dressings. Dr. Liu has led several research and teaching reform projects, obtained a patent transformation, and contributed to national and provincial-level scientific investigations. Her innovative work in tissue engineering and skin trauma treatment continues to contribute significantly to biomedical science and material engineering.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Specialized Expertise
    Dr. Liu focuses on biomechanics in disease development, particularly related to cutaneous trauma (e.g., burns, radiotherapy), a niche but critical area in biomedical engineering.

  2. Material Innovation
    Her work in developing tissue-engineered skin and antibacterial dressings demonstrates applied innovation with potential clinical relevance.

  3. Project Leadership
    Successfully led and participated in multiple competitive research projects funded by national and provincial bodies, indicating trust in her scientific vision and capabilities.

  4. Research Productivity
    Though early in recognition, Dr. Liu has already co-authored several peer-reviewed journal articles in reputable publications like Scientific Reports and Placenta, which reflect growing academic contribution.

  5. Translational Research
    Her involvement in a patent achievement transformation shows a commitment to moving research beyond the lab into real-world applications.

🔧 Areas for Improvement:

  1. Citation Impact and Indexing
    The provided articles currently have 0 citations, and there is no citation index or h-index reported. Increasing publication visibility and citation impact should be a future focus.

  2. Global Recognition and Collaboration
    There is no mention of international collaboration, editorial roles, or professional memberships, which would enhance credibility and reach.

  3. Documented Industry Linkages
    Despite some project engagement with enterprises, more evidence of sustained industry partnerships or commercialization success would strengthen the application.

  4. Books, Patents, and Conferences
    Absence of published books, patents in process, or keynote roles in international conferences limits the academic portfolio breadth.

🎓 Education:

Although specific degree details are not listed, Dr. Yang Liu has built a strong academic foundation that supports her expertise in biomedical engineering and biomechanics. Her academic journey is closely aligned with her professional role at Taiyuan University of Technology, which is known for its technical research capabilities. Dr. Liu’s knowledge spans skin tissue biology, mechanical trauma, and biomedical materials science, indicating a background that likely includes degrees in biomedical engineering, bioengineering, or a related field. Her educational experience has equipped her with the skills necessary to conduct high-level research in skin regeneration, materials science, and tissue biomechanics. Additionally, her active participation in national scientific projects and her leadership in academic innovation at the university level point to rigorous formal training and ongoing academic development.

🧪 Experience:

Dr. Yang Liu has over a decade of professional experience in biomedical research since joining the Taiyuan University of Technology in 2013. Her work has revolved around exploring the mechanical and biological factors involved in traumatic skin injury and healing. She has successfully led and contributed to multiple projects, including those funded by the National Natural Science Foundation of China and enterprise collaborations. In addition to her scientific contributions, she has also directed teaching reform projects and a patent transformation, highlighting her dual commitment to both research and education. Her experience includes a strong focus on interdisciplinary collaboration across biology, materials science, and mechanical engineering. This breadth of experience has allowed her to develop innovative biomedical materials, such as tissue-engineered skin and functional skin dressings, aimed at improving clinical treatment outcomes for burn injuries and other trauma-related skin conditions.

🔬 Research Focus:

Dr. Yang Liu’s research centers on the biomechanics of skin tissue damage and healing, with an emphasis on cutaneous trauma from burns and radiotherapy. Her work investigates how mechanical forces impact skin at multiple biological levels—molecular, cellular, tissue, and animal models. A major portion of her research explores biomedical material innovation, particularly tissue-engineered skin, skin dressings, and antibacterial materials. She is particularly focused on understanding how structural and mechanical properties of these materials can improve therapeutic outcomes. Dr. Liu also studies oxidative stress, cell migration, and protein responses under mechanical pressure, making her work crucial to trauma therapy and regenerative medicine. With a patent transformation and multiple research projects to her credit, her research is positioned at the intersection of engineering innovation and clinical application, aiming to reduce complications in skin trauma treatment and enhance recovery efficiency through scientifically engineered materials.

📚 Publications Top Notes:

  1. 🧴🧬 Preparation and characterization of nano-silver/graphene oxide antibacterial skin dressing – Scientific Reports, 2025

  2. 🔬⛽ Experimental study on liquid products and pore structure characteristics of anthracite saturated by supercritical CO₂ – Gas Science and Engineering, 2025

  3. 🧠💥 The regulatory role of the nuclear scaffold protein Emerin on the migration of amniotic epithelial cells and oxidative stress in a pressure environment – Placenta, 2025

  4. 🛠️🔥 Annealing Response of Cold-rolled Ti₂AlNb Based Alloy Foil in Different Phase Regions – Tezhong Zhuzao Ji Youse Hejin (Special Casting and Nonferrous Alloys), 2025

📝 Conclusion:

Dr. Yang Liu shows significant promise as a biomedical researcher, with a clear, focused research trajectory, practical outputs (materials for skin regeneration), and consistent project engagement at institutional and national levels. While her global visibility and citation metrics are currently limited, her research has high translational potential in trauma medicine and biomedical materials, making her a strong emerging contender for the Best Researcher Award—especially under a category recognizing early- to mid-career researchers with impactful applied science work.

Zhijie Chang | Extracellular Vesicles | Cell Communication Award

Published on by Cell Biologist

Prof. Zhijie Chang | Extracellular Vesicles | Cell Communication Award

Prof. Zhijie Chang, Tsinghua University, China

Professor Zhijie Chang is a distinguished molecular biologist and tenured professor at the School of Medicine and School of Life Sciences, Tsinghua University, Beijing. His research spans cancer signaling pathways, extracellular vesicle-mediated communication, and stem cell therapy, especially in lung diseases and tumor biology. A seasoned scholar, Dr. Chang earned his Ph.D. in Animal Genetics and Breeding before undertaking postdoctoral training at the University of Alabama at Birmingham. He is currently a respected editor of FEBS Letters and a leader in molecular oncology in China. His recent works highlight the role of CREPT, Smad signaling, and macrophage modulation in cancer and fibrosis. Through decades of academic and translational research, he has significantly advanced our understanding of cell communication in disease contexts. With an extensive publication record in top journals, Dr. Chang remains a leading figure in Asia’s biomedical research landscape.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Pioneering Contributions in Cell Communication
    Prof. Chang’s research on CREPT, Smad proteins, NF-κB/Nrf2, and BMP signaling has directly advanced the understanding of how intracellular and intercellular communication impacts disease progression, especially in cancer and pulmonary disorders.

  2. High-Impact Publications
    He has numerous peer-reviewed articles in prestigious journals such as Nature Communications, Molecular Cancer, Signal Transduction and Targeted Therapy, and Journal of Biological Chemistry, many of which explore molecular and cellular communication in cancer and tissue repair.

  3. Translational Focus
    His integration of mesenchymal stem cell therapy, extracellular vesicles, and gene therapy reflects a strong translational approach, applying basic science to therapeutic innovations—a critical criterion for this award.

  4. Scientific Leadership and Mentorship
    As a tenured professor at Tsinghua University and editor at FEBS Letters, Prof. Chang is a leader in biomedical research and scientific dissemination, actively contributing to academic growth and mentorship.

⚠️ Areas for Improvement:

  1. More Global Recognition
    While well-known in Chinese biomedical circles and respected internationally through publications, increased involvement in global consortia or leadership in international collaborations would further solidify his global scientific footprint.

  2. Public/Community Science Engagement
    Enhancing visibility through public lectures, science communication platforms, or policy advisory roles could broaden the societal impact of his work.

  3. Data-Sharing and Open Science Practices
    Encouraging or highlighting open-access datasets, repositories, or reproducible workflows would align with best practices in modern cell communication research.

🎓 Education:

Professor Zhijie Chang began his academic journey at Northwestern Agricultural University in Yangling, China, where he earned his B.Sc. (1978–1982) in Animal Science. He then continued at the same institution to obtain a combined M.Sc. and Ph.D. in Animal Genetics and Breeding from 1982 to 1989. His graduate research laid the foundation for his future in molecular biology, signaling studies, and genetics. Seeking international exposure and advanced training, he undertook postdoctoral research from March 1997 to October 1998 at the University of Alabama at Birmingham, USA, in the Department of Pathology. There, he specialized in the BMP signaling pathway, gaining expertise in molecular signaling processes critical to cell communication. This blend of domestic and international education has equipped Dr. Chang with both the technical rigor and global perspective needed to pioneer breakthroughs in biomedical science.

💼 Professional Experience:

Professor Zhijie Chang has held a full professorship at Tsinghua University’s School of Medicine since June 2005, where he investigates cancer-related signaling mechanisms. Before this, he completed postdoctoral research at the University of Alabama at Birmingham, focusing on BMP signaling, which strengthened his understanding of developmental and pathological cell signaling. Over the years, he has built a highly productive research lab, contributed extensively to translational medicine, and trained numerous doctoral and postdoctoral researchers. As an editor of FEBS Letters, he also contributes to scientific publishing and peer-review processes. His roles across academia, research, and editorial boards mark him as a multifaceted scientist whose work bridges laboratory insights and therapeutic applications. His collaborative style and consistent research funding reflect his leadership and innovation in molecular oncology and regenerative medicine.

🏅 Awards and Honors:

Professor Zhijie Chang has been recognized multiple times by the Chinese Cell Biology Society for his high-impact publications. In 2003, he received the First Merit Paper Award for his groundbreaking research on hSef-mediated MAPK signaling inhibition in J. Biol. Chem. In 2005, he earned the Third Merit Paper Award for his study on CHIP-mediated degradation of Smad proteins, published in Mol. Cell. Biol.. These awards underscore his early and sustained contributions to deciphering molecular signaling pathways involved in cell communication, differentiation, and oncogenesis. His recent recognitions include publications in top-tier journals like Nature Communications, Molecular Cancer, and Signal Transduction and Targeted Therapy, indicating the continued relevance and innovation of his work. His role as an editor for FEBS Letters further highlights his stature in the field and dedication to advancing cell biology research at national and international levels.

🔬 Research Focus:

Dr. Zhijie Chang’s research primarily investigates cellular communication in cancer and inflammatory diseases, with a focus on CREPT, Smad proteins, and extracellular vesicles. His work dissects how tumor-derived signals modulate the tumor microenvironment, metastasis, and immune cell behavior. He has made critical discoveries regarding the role of CREPT in chromatin looping and transcriptional regulation, especially in triple-negative breast cancer. In pulmonary fibrosis models, he has shown how umbilical cord-derived mesenchymal stem cells (MSCs) modulate macrophage activity via secreted vesicles. Another major area is his exploration of Smurf1, PDK1–Akt, and JAK/STAT3 signaling axes, targeting them for therapeutic intervention in various cancers. His translational approach integrates gene therapy, stem cell-based treatments, and protein signaling studies, bridging basic and clinical sciences. Through collaborative and interdisciplinary methods, Dr. Chang contributes valuable insights into how cells communicate and respond in disease settings.

📚 Publication Top Notes:

  1. 📘 CREPT is required for the metastasis of triple-negative breast cancer through a co-operational-chromatin loop-based gene regulation

  2. 🧪 Clinical investigation on nebulized human umbilical cord MSC-derived extracellular vesicles for pulmonary fibrosis treatment

  3. 🧬 Gene Therapy with Enterovirus 3C Protease: A Promising Strategy for Various Solid Tumors

  4. 🌬 Umbilical cord-derived mesenchymal stem cells preferentially modulate macrophages to alleviate pulmonary fibrosis

  5. ⚡ CREPT upregulates the antioxidant genes via activation of NF-κB/Nrf2 in acute liver injury

  6. 🔁 An oncoprotein CREPT functions as a co-factor in MYC-driven transformation and tumor growth

  7. 🎯 Targeting Smurf1 to block PDK1–Akt signaling in KRAS-mutated colorectal cancer

  8. 📤 Microenvironment-induced CREPT expression by cancer-derived small extracellular vesicles primes field cancerization

  9. 🔋 Oxidative phosphorylation safeguards pluripotency via UDP-N-acetylglucosamine

  10. 🍄 Lachnochromonin, a fungal metabolite from Lachnum virgineum, inhibits cell growth and promotes apoptosis in tumor cells through JAK/STAT3 signaling

🧾 Conclusion:

Professor Zhijie Chang exhibits a robust and well-established career built on investigating mechanisms of cell signaling, tumor microenvironment dynamics, and intercellular communication. His scientific rigor, translational impact, and leadership in the field of cell communication make him an outstanding candidate for the Research for Cell Communication Award. Addressing some broader outreach and open science practices could further elevate his profile, but his contributions to foundational and applied research in this domain are already exemplary.

Chenlong YANG | Cancer Cell Biology | Best Researcher Award

Published on by Cell Biologist

Prof. Chenlong YANG | Cancer Cell Biology | Best Researcher Award

Prof. Chenlong YANG, Peking University Third Hospital, China

Dr. Chenlong Yang, M.D., Ph.D., is an accomplished neurosurgeon and research associate professor at the Department of Neurosurgery, Peking University Third Hospital. With over 15 years of clinical and research experience, he specializes in neuro-oncology, spinal neurosurgery, and translational neuroscience. Dr. Yang earned his M.D. from Shandong University and his Ph.D. in Neurological Surgery from Capital Medical University. He has trained and worked in prestigious institutions including Beijing Tiantan Hospital and the State Key Laboratory of Vascular Homeostasis and Remodeling. He has contributed significantly to advancements in brain tumor diagnostics, neuroimmunology, and surgical innovations, with numerous high-impact publications. Recognized internationally, he frequently presents at top neurosurgical conferences such as EANS and the Japan-China Neurosurgery Alliance. His research bridges basic science and clinical neurosurgery, aiming to improve surgical precision and therapeutic outcomes. Dr. Yang is also known for his leadership in collaborative, multidisciplinary research teams.

Publication Profile: 

Google Scholar

✅ Strengths for the Award:

  1. 📚 Robust Academic and Clinical Training

    • Earned an M.D. from Shandong University and a Ph.D. in Neurological Surgery from Capital Medical University.

    • Completed clinical training at Beijing Tiantan Hospital, a top-tier neurosurgical institution in China.

  2. 🔬 Multidisciplinary and Translational Research Excellence

    • His research spans neuro-oncology, neuroimmunology, spinal neurosurgery, and advanced neuroimaging.

    • Conducted preclinical work on Alzheimer’s disease models and neuroprotection, along with current research in immune checkpoint therapy and intraoperative imaging.

  3. 📈 High-Impact Publications

    • Over 20 peer-reviewed publications in journals such as Scientific Reports, J Exp Clin Cancer Res, Neurosurgical Review, and Biophysical Journal.

    • His research on chordomas, gliomas, and spinal tumors has significantly contributed to the field.

  4. 🌍 International Recognition

    • Speaker at major international conferences like EANS 2025 and KSNS 2024.

    • Previously awarded a scholarship by the Turkish Neurosurgical Society.

  5. 🤝 Leadership in Collaboration

    • Plays a key role at the Center for Precision Neurosurgery and Oncology and the State Key Laboratory of Vascular Homeostasis and Remodeling, fostering interdisciplinary collaborations across neurosurgery, imaging, and immunotherapy.

  6. 🎯 Focus on Precision and Innovation

    • Pioneering high-resolution MRI techniques, fluorescent intraoperative navigation, and predictive modeling for neurosurgical outcomes.

🔄 Areas for Improvement:

  1. 📊 Independent Research Lead

    • While he has several corresponding author papers, increasing his share of first-author or sole-PI grants would further elevate his research identity.

  2. 🌐 Global Collaborations

    • Though he has spoken at international conferences, expanding collaborative projects with leading global neuroscience centers could amplify impact.

  3. 💡 Technology Commercialization

    • Given his innovation in imaging and diagnostics, pursuing intellectual property rights or translational funding (e.g., for clinical tools or surgical systems) could be a valuable next step.

  4. 📄 Diversification of Research Outputs

    • A few review articles and meta-analyses would strengthen his role as a thought leader and field synthesizer.

📘 Education:

Dr. Yang pursued his foundational medical education at Shandong University, earning an M.D. in Clinical Medicine (2006–2011). This training provided a solid clinical base and early exposure to neurology and internal medicine. He then advanced to a doctoral program at Capital Medical University, Beijing (2011–2017), earning his Ph.D. in Neurological Surgery. During his Ph.D., he received specialized training in neurosurgical techniques and engaged in cutting-edge research, particularly focusing on neuro-oncology and degenerative neural diseases. As part of his early research career, he also worked at the Institute of Neurobiology, Shandong University, investigating neuroprotective agents and Alzheimer’s disease models. Dr. Yang’s academic journey is characterized by rigorous clinical training and scientific inquiry, equipping him with the knowledge and skills essential for bridging the gap between the lab bench and the operating room. His education laid a strong foundation for his future contributions to precision neurosurgery and translational neuroscience.

💼 Experience:

Dr. Yang has over a decade of diversified experience across top medical and research institutions. He currently serves as a Research Associate Professor and Attending Physician at the Department of Neurosurgery, Peking University Third Hospital (2020–present), where he leads several clinical and translational research projects. Prior to this, he completed a postdoctoral fellowship (2017–2020) in the Department of Orthopedics at the same hospital, emphasizing spinal and neuro-oncologic conditions. From 2011 to 2017, he worked as a resident in Neurosurgery at Beijing Tiantan Hospital, one of China’s premier neurosurgical centers, gaining extensive experience in surgical treatments and neurovascular procedures. His roles span clinical surgery, research coordination, and academic instruction. Additionally, he actively contributes to the Center for Precision Neurosurgery and Oncology and the State Key Laboratory of Vascular Homeostasis and Remodeling, leading initiatives to improve patient outcomes through interdisciplinary innovations in neurosurgical care.

🧠 Research Focus:

Dr. Chenlong Yang’s research integrates neurosurgery, oncology, immunology, and biomedical engineering. His primary focus lies in neuro-oncology, with a strong emphasis on chordoma biology, glioma immunotherapy, and molecular diagnostics. He explores immune checkpoint therapies, tumor microenvironment modulation, and the development of predictive models for neurosurgical complications such as postoperative delirium. Dr. Yang is also deeply involved in technological innovation in neurosurgery, investigating intraoperative fluorescence imaging, high-resolution MRI, and minimally invasive spinal techniques. His work on spatial learning, Alzheimer’s models, and neuroprotection during his early career continues to inform his translational research. He collaborates across disciplines, from molecular biologists to radiologists, aiming to build precision-guided therapeutic frameworks. His research is extensively published in journals like Scientific Reports, J Exp Clin Cancer Res, and Frontiers in Neurology. Through this work, Dr. Yang seeks to advance the standard of care in neurosurgical oncology and promote patient-specific interventions.

📚 Publication Top Notes:

  1. 🧬 SMARCB1 orchestrates cellular plasticity and oncogenic pathways in typical and chondroid chordomas

  2. 🛡️ Cracking Chordoma’s Conundrum: Immune Checkpoints Provide a Potential Modality

  3. 🌱 From glioma gloom to immune bloom: unveiling novel immunotherapeutic paradigms – a review

  4. 💡 Intraoperative fluorescence redefining neurosurgical precision

  5. 🧠 The evolution and integration of technology in spinal neurosurgery: A scoping review

  6. 👁️ Single-cell transcriptomic atlas of aging macaque ocular outflow tissues

  7. 🧮 Risk stratification and predictive modeling of postoperative delirium in chronic subdural hematoma

  8. 📶 Characteristic fingerprint spectrum of α-synuclein mutants on terahertz time-domain spectroscopy

  9. 🐒 Normative profile of retinal nerve fiber layer thickness in cynomolgus monkeys

  10. 🌀 Accurate diagnosis and treatment of sacral meningeal cysts using high-resolution MRI

  11. 🧪 Intraspinal hemangioblastomas: analysis of 92 cases in a single institution

🏁 Conclusion:

Dr. Chenlong Yang exemplifies the ideal profile of a cutting-edge clinician-scientist, merging neurosurgical precision with immunological insight and technological innovation. His commitment to patient-centered research, consistent academic output, and recognition on international platforms underscores his eligibility for the Best Researcher Award. With continued growth in independent leadership and global research impact, Dr. Yang is not only a deserving candidate now but is poised to become a prominent global figure in neurosurgical research in the years to come.

Marcos Jessé Abrahão Silva | Cell Biology | Best Researcher Award

Published on by Cell Biologist

Mr. Marcos Jessé Abrahão Silva | Cell Biology | Best Researcher Award

Mr. Marcos Jessé Abrahão Silva, State University of Pará (UEPA), Brazil

Marcos Jessé Abrahão Silva is a Brazilian biomedical scientist and Ph.D. student at the State University of Pará (UEPA), specializing in immunogenetics and molecular biology. He holds a Bachelor’s in Biomedicine from UNAMA and a Master’s in Epidemiology and Health Surveillance from the Evandro Chagas Institute. Marcos has contributed to over 35 technical-scientific publications, including high-impact journals such as Frontiers in Immunology and Microorganisms, and has accumulated more than 260 citations. He’s a published author of multiple scientific books and a reviewer for prestigious journals like Current Microbiology. His research spans infectious diseases like COVID-19, leprosy, HIV, and bacterial resistance. As a member of Sigma Xi, his academic dedication has earned him editorial appointments and international collaborations, including with Tulane University. Currently, Marcos leads research on HIV prevention in vulnerable groups using innovative approaches via social media under the project “raprev.aids”.

Publication Profile:

Google Scholar

✅ Strengths for the Award:

  1. Strong Publication Record 📚
    Marcos has authored or co-authored over 35 scientific publications, with more than 20 in high-impact journals (JCR indexed) such as Frontiers in Immunology, Viruses, Microorganisms, and Genes—an exceptional record for a Ph.D. student.

  2. Global Citation Impact 🌍
    His Google Scholar h-index of 7, Scopus h-index of 7, and Web of Science h-index of 6—along with 260+ citations—reflect international academic recognition and influence.

  3. Multidisciplinary Research Expertise 🧬
    His work integrates epidemiology, immunogenetics, molecular biology, and bioinformatics, focusing on infectious diseases including COVID-19, HIV, leprosy, and paracoccidioidomycosis, which are highly relevant to global health.

  4. Editorial and Peer-Review Roles ✍️
    Marcos is a reviewer for top journals, including CURRENT MICROBIOLOGY, and serves on the editorial board of the International Journal of Genetics—demonstrating leadership in academic publishing.

  5. International and Institutional Collaboration 🤝
    He collaborates with respected institutions like Evandro Chagas Institute, Federal University of Ceará, and Tulane University, expanding the impact of his research across borders.

  6. Innovation in Health Communication 💡
    He is currently leading a social innovation project (raprev.aids) combining science, technology, and culture for HIV prevention among vulnerable populations using digital and artistic media—a model for translational science.

⚠️ Areas for Improvement:

  1. First-Author Leadership in Top-Tier Journals
    While co-authorship is strong, more consistent first-author publications in Q1 journals would further solidify his leadership in research.

  2. Patent Contributions & Industry Linkages
    Although experienced in academic research, strengthening links with biomedical industry or technology transfer (patents) could amplify his societal and commercial impact.

  3. Global Networking
    Participation in more international conferences or fellowships would further raise his visibility on the global scientific stage.

🎓 Education0:

Marcos Jessé Abrahão Silva’s academic foundation is rooted in Biomedicine, having completed his Bachelor’s degree at the University of the Amazon (UNAMA) from 2018 to 2021. Following this, he earned his Master of Science degree from the prestigious Evandro Chagas Institute (IEC) through the Postgraduate Program in Epidemiology and Health Surveillance (2021–2023). He is currently pursuing his Ph.D. in Parasitology Biology in the Amazon at the State University of Pará (UEPA). Additionally, he is specializing in Bioinformatics at the Federal Technological University of Paraná (UTFPR), expected to complete in 2025. His educational trajectory reflects a strong emphasis on translational research, infectious disease epidemiology, and molecular diagnostics. Marcos has also been inducted as an official member of Sigma Xi, The Scientific Research Honor Society, highlighting his academic and professional distinction. His interdisciplinary education supports his work in cutting-edge biomedical and public health research.

🧪 Experience:

Marcos Jessé has developed extensive research experience in immunogenetics, molecular biology, and epidemiology. He has actively participated in significant research projects, such as the Hansen’s Immunogenetic Study and COVID-19 response analysis in Brazil. Marcos has co-authored more than 35 scientific publications, including international peer-reviewed journals, and written chapters in academic books on infectious diseases. His roles have included principal investigator, project member, and scientific reviewer for journals like Current Microbiology. He also has experience in scientific consulting and is involved in translational research, particularly focusing on disease susceptibility genetics. Marcos collaborates with leading institutions like the Evandro Chagas Institute, Federal University of Ceará, and Tulane University. Beyond academic research, he contributes to community-based health innovation through HIV prevention projects involving social media outreach. He has served in editorial roles and has been recognized with international awards for his scientific contributions, making him a standout emerging researcher from the Global South.

🔍 Research Focus:

Marcos Jessé Abrahão Silva’s research centers on immunogenetics, infectious diseases, and molecular biology, with a special emphasis on diseases endemic to Brazil and the Amazon. He investigates the genetic factors influencing susceptibility to pathogens like Mycobacterium leprae, HIV-1, and SARS-CoV-2, often analyzing Single Nucleotide Polymorphisms (SNPs) and immune response mechanisms. His work aims to unravel how innate and adaptive immune pathways contribute to disease severity, particularly in viral and bacterial infections. Marcos has conducted systematic reviews and meta-analyses to clarify the epidemiological role of genetic polymorphisms. His recent focus includes a culturally innovative HIV prevention project, “raprev.aids,” integrating artistic and scientific communication via social networks. He is also active in studying antimicrobial resistance, such as in Pseudomonas aeruginosa. His research goal is to bridge laboratory science with public health practice, particularly in vulnerable populations across the Amazon and broader Latin America.

📚 Publications Top Notes:

  1. 🧫 Hyperinflammatory response in COVID-19: a systematic review – Viruses

  2. 🧠 Adaptive immunity to SARS-CoV-2 infection: A systematic review – Frontiers in Immunology

  3. 🧬 Innate immunity to SARS-CoV-2 infection: a review – Epidemiology & Infection

  4. 🧪 The Relationship between TLR3 rs3775291 Polymorphism and Infectious Diseases: A Meta-Analysis – Genes

  5. 🧫 The Association between CCL5/RANTES SNPs and Susceptibility to HIV-1 Infection: A Meta-Analysis – Viruses

  6. 🧬 The relationship between 896A/G (rs4986790) polymorphism of TLR4 and infectious diseases: A meta-analysis – Frontiers in Genetics

  7. 🦠 Endemic High-Risk Clone ST277 & SPM-1-Producing P. aeruginosa During COVID-19 in Brazil – Microorganisms

  8. 🧫 Prevalence of MβL-Producing P. aeruginosa in Brazil: A Meta-Analysis – Microorganisms

  9. 🐀 The Presence of Mycobacterium leprae in Wild Rodents – Microorganisms

  10. 🧬 Associations between TLR3 SNPs and COVID-19 in Belém-PA Professionals – Frontiers in Cellular and Infection Microbiology

🔍 Conclusion:

Marcos Jessé Abrahão Silva is an exceptionally promising early-career researcher whose contributions already surpass many peers at the same academic stage. His proven scientific output, international citation record, and commitment to public health innovation make him highly suitable for the Best Researcher Award. His research not only addresses local health challenges in the Amazon and Brazil but also contributes meaningfully to the global understanding of infectious diseases and immune responses.

Veronica Gagliardi | microcirculation | Best Researcher Award

Published on by Cell Biologist

Dr. Veronica Gagliardi | microcirculation | Best Researcher Award

Dr. Veronica Gagliardi, Università degli studi di Padova, Italy

Dr. Veronica Gagliardi is an Italian Medical Doctor specializing in Anaesthesiology, Resuscitation, Intensive Care, and Pain Therapy. Born on August 22, 1996, in Spinea (VE), she is currently undergoing advanced clinical training at the University of Padua, where she has also undertaken a Level II Master in multimodal cardiac imaging. She combines academic excellence with frontline clinical experience in major regional hospitals, including Ospedale dell’Angelo in Mestre and Policlinico Universitario di Padova. Her work focuses on intensive care medicine, advanced echocardiography, and non-invasive ventilation strategies. Dr. Gagliardi is widely published, with a strong record in critical care, pain therapy, and ultrasound techniques. Her proactive involvement in clinical research and innovative therapies, including ECMO and auricular acupuncture, reflects a strong commitment to scientific advancement in patient care. She is a promising researcher and clinician, striving to integrate cutting-edge evidence with compassionate care.

Publication Profile:

Scopus

✅ Strengths for the Award:

  1. Extensive Research Portfolio:
    Dr. Gagliardi has authored and co-authored over 10 peer-reviewed publications across respected international journals (Life, Medicina, Critical Care, Cureus, EJTM, Arch Clin Biomed Res), covering high-impact areas like ECMO, microcirculation, pain therapy, and non-invasive ventilation.

  2. Clinical-Research Integration:
    Her ability to bridge clinical practice and research is a standout quality. From ECMO and PEEP titration in COVID-19 to auricular electroacupuncture and ultrasound-guided pain procedures, she applies science directly to bedside care.

  3. Strong Academic Record:
    With a Medical Degree cum laude (110/110) and advanced training at the University of Padua, she demonstrates academic excellence, now furthered by a Level II Master in echocardiographic imaging.

  4. Leadership and Collaboration:
    She has actively participated in multi-center projects and international symposia, indicating both team leadership and scientific communication skills.

  5. Innovation and Versatility:
    Her research includes novel and multidisciplinary approaches—like capsaicin patch use for neuropathic pain and auricular diagnostics in oncology contexts.

⚙️ Areas for Improvement:

  1. Recognition and Awards:
    While her work is highly impactful, Dr. Gagliardi may benefit from more formal recognition, such as national/international fellowships, grants, or young investigator awards.

  2. Independent Research Funding:
    Securing her own research grants in the near future would further strengthen her research independence and global visibility.

  3. Broader Dissemination:
    Increasing her presence through conference presentations, keynote talks, or editorial roles would amplify the visibility of her work and boost her academic footprint.

🎓 Education:

Dr. Veronica Gagliardi earned her Master’s Degree in Medicine and Surgery with 110/110 with Honours from the University of Padua, completing an experimental thesis under Prof. Paolo Navalesi on respiratory failure in COVID-19 patients. Since November 2021, she has been enrolled in a five-year residency program in Anaesthesiology, Resuscitation, Intensive Care, and Pain Therapy at the same institution, with rotations in several prominent hospitals. Starting November 2024, she will also undertake a Level II Master (ESTAV) in stress echocardiography, advanced transesophageal, and multimodal cardiac imaging, focusing on perioperative and interventional cardiac ultrasound techniques. Her education reflects not only clinical rigor but also a keen interest in research and innovation, particularly in areas like non-invasive ventilation, ultrasound diagnostics, and pain modulation. Her academic background is complemented by strong scientific output and peer-reviewed contributions in high-impact journals.

💼 Professional Experience:

Dr. Gagliardi has held the role of Medical Doctor specializing in Anaesthesiology and Intensive Care at Ospedale dell’Angelo in Mestre, starting in January 2025. Initially assigned to general anaesthesiology (UOS), she has since progressed to the Cardiac Intensive Care Unit (UOS) from May 2025. Her residency training from November 2021 to January 2025 included rotations in premier institutions such as Policlinico Universitario di Padova, Ospedale S. Antonio, Ospedale Ca’ Foncello, and Ospedale SS Giovanni e Paolo, gaining experience in critical care, pain therapy, perioperative medicine, and emergency interventions. Throughout her career, she has consistently demonstrated clinical versatility, excelling in high-pressure ICU settings. She combines clinical competence with advanced procedural skills, including echocardiography and ultrasound-guided regional blocks. This diverse clinical exposure underpins her contribution to complex case management and patient-centered care.

🏅 Awards and Honors:

Dr. Veronica Gagliardi has not been explicitly listed with specific awards, but her academic and research profile clearly reflects recognition-worthy achievements. She graduated with honors (110/110 cum laude) in Medicine, which stands as an early testament to her dedication and excellence. Her first-author publications in indexed journals, such as Life, Medicina, Critical Care, and EJTM, highlight her as a leading contributor to translational and clinical research in anesthesiology and critical care. Her participation in international symposiums, including the 40th International Symposium on Intensive Care & Emergency Medicine, and collaborations with established experts like Prof. Navalesi, further underscore her growing reputation. While formal honors such as Best Researcher Awards are yet to be listed, her CV is aligned with the standards of excellence and would merit such recognition in academic and clinical research circles.

🔬 Research Focus:

Dr. Gagliardi’s research is deeply rooted in critical care medicine, with a strong emphasis on microcirculation, non-invasive ventilation, pain management, and echocardiographic imaging. Her work spans experimental and clinical domains—from animal models exploring systemic morphine’s anti-inflammatory effects, to human studies on ECMO efficiency and caudal epidural injections. She has delved into innovative diagnostics like diaphragm ultrasound for predicting extubation outcomes, and non-conventional therapies such as auricular electro-acupuncture for microcirculatory modulation. Her research extends into the perioperative and post-operative use of non-invasive respiratory support, and stress echocardiography, bridging imaging and intensive care management. She actively collaborates on multi-center reviews and pilot studies, showing both independence and teamwork. Dr. Gagliardi’s research consistently aims at improving patient outcomes through evidence-based and minimally invasive approaches, contributing significantly to the evolving landscape of modern anaesthesia and critical care.

📚 Publications Top Notes:

📄 The Effects of Levosimendan on Microcirculation and Peripheral Perfusion in Septic Shock: A Pilot Study
📄 Recirculation in Veno-Venous Extracorporeal Membrane Oxygenation
📄 A Possible Correlation Between Auricular Angiomas and Breast Cancer Through Auricular Acupuncture Diagnosis: An Observational Case-Control Study
📄 Ultrasound-guided caudal epidural injection to treat symptoms of lumbar spinal stenosis: a retrospective study
📄 Effects of noninvasive respiratory support in post-operative patients: a systematic review and network meta-analysis
📄 Systemic Morphine but Not Local Administration Shows Preventive Anti-Inflammatory Effect in a Rat Model of Capsaicin-Induced Paw Edema
📄 Effect of Low- and High-Frequency Auricular Stimulation with Electro-Acupuncture on Cutaneous Microcirculation: A Cross-Over Study in Healthy Subjects
📄 Diaphragm Ultrasound: A Valuable Predictor of the Outcome of Extubation. An Observational Pilot Study in Covid-19 Related ARDS
📄 Persistent neuropathic pain treated with Capsaicin patches: a novel promising approach
📄 P101 Execution of percutaneous dilatational tracheostomy using the standard laryngeal mask airway for ventilation: a prospective survey study
📄 Positive end-expiratory pressure titration in COVID-19 acute respiratory failure: electrical impedance tomography vs. PEEP/FiO2 tables

🧾 Conclusion:

Dr. Veronica Gagliardi is an exceptional emerging researcher who combines clinical acumen with a robust scientific mindset. Her research is innovative, clinically relevant, and methodologically sound, spanning critical areas like sepsis management, ECMO, echocardiography, and noninvasive ventilation strategies.

Yong-Soo Bae | Immunology Cellular Interactions | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Yong-Soo Bae | Immunology Cellular Interactions | Best Researcher Award

Prof. Dr. Yong-Soo Bae | Sungkyunkwan University | South Korea

Dr. Yong-Soo Bae is a distinguished immunologist and professor at the Department of Biological Science, Sungkyunkwan University, Korea. He currently serves as the Director of the SRC Center for Immune Research on Non-lymphoid Organs (CIRNOS). With over three decades of academic, clinical, and industry experience, Dr. Bae is internationally recognized for his pioneering research in immunology, virology, and vaccine development. His multidisciplinary contributions span academia, biotech innovation (as CEO/CTO of JW Creagene Inc.), and scientific leadership, including organizing global conferences and serving as editor-in-chief and president in numerous societies. His work focuses on immune modulation, cancer immunotherapy, and mucosal vaccines, which has led to influential publications in prestigious journals like Nature Communications, Science Advances, and Advanced Materials. Dr. Bae’s career reflects a commitment to innovation, collaboration, and education, making him a strong candidate for the Best Researcher Award.

Publication Profile:

Scopus

✅ Strengths for the Award

  1. Pioneering Research Leadership
    Dr. Bae has led groundbreaking research in immunology, particularly in immune regulation of non-lymphoid organs, vaccine development, and cancer immunotherapy. His leadership of the Center for Immune Research on Non-lymphoid Organs (CIRNOS) demonstrates his national influence in immune research.

  2. Extensive Scientific Contributions
    With over 18 high-impact publications in the past 3–4 years alone, including in top-tier journals like Nature Communications, Molecular Therapy, Science Advances, and Advanced Materials, Dr. Bae continues to push the boundaries of translational immunology and personalized medicine.

  3. International & Interdisciplinary Experience
    His training at Harvard Medical School, his professorships across Korean institutions, and leadership at JW Creagene Inc. showcase both academic and industrial impact.

  4. Scientific Community Engagement
    Roles such as Editor-in-Chief, society president, and organizer of global conferences (e.g., DC2012) reflect his commitment to advancing scientific dialogue and collaboration.

  5. Mentorship and Institutional Development
    Dr. Bae has contributed significantly to capacity building in Korea’s biomedical research landscape, mentoring junior scientists and shaping departmental growth.

⚠️ Areas for Improvement:

  1. Global Collaboration Visibility
    While his work is highly impactful in Korea and Asia, more joint publications with global institutions (e.g., NIH, Oxford, Karolinska) could further enhance international research influence.

  2. Patent and Commercial Output Reporting
    As former CEO/CTO of JW Creagene, elaborating on patented innovations or therapeutic products brought to market would strengthen the case for translational impact.

  3. Formal Recognition or Awards
    Inclusion of formal honors (e.g., national science medals, international society awards) would help quantify his recognition outside Korea.

  4. Consistent Author Disambiguation
    In some publications, author names appear as “Y.S. Bae” or “Yong-soo Bae.” Consistent use of a standardized author name across indexing platforms would help centralize his citation metrics and scholarly footprint.

 

🎓 Education:

Dr. Yong-Soo Bae’s academic journey began with a Bachelor’s and Master’s degree in Microbiology from Seoul National University in 1981 and 1983, respectively. His foundational training in microbiology laid the groundwork for his research trajectory in infectious disease and immunology. He earned his Ph.D. in 1990 from the University of Calgary, Alberta, Canada, in the Virology Division of the Department of Microbiology and Infectious Diseases, Faculty of Medicine. His doctoral research was crucial in shaping his interest in host-pathogen interactions and immune regulation. Dr. Bae’s international education experience has enabled him to blend Western and Eastern biomedical research paradigms, contributing to his ability to lead collaborative global projects and initiatives in immunotherapy and vaccine innovation.

💼 Experience:

Dr. Yong-Soo Bae’s professional career spans academia, research, and biotech leadership. He completed a postdoctoral fellowship at Dana-Farber Cancer Institute, Harvard Medical School (1991–1993), which enriched his expertise in cancer immunology. He held professorial roles at Hannam University (1993–2003) before joining Sungkyunkwan University in 2004, where he later became Department Chair and Distinguished Professor. Dr. Bae also served as Director of CIRNOS (2017–2024) and led JW Creagene Inc. as CEO/CTO (1998–2015), bridging science and industry. His editorial and leadership roles include Editor-in-Chief of the Journal of Bacteriology and Virology, President of the Korean Society of Virology, and Vice President of the Korean Vaccine Society. His diverse roles demonstrate a unique blend of academic excellence, organizational leadership, and translational research expertise.

🔍 Research Focus:

Dr. Yong-Soo Bae’s research focuses on innate and adaptive immune regulation, tumor immunology, mucosal immunotherapy, and vaccine delivery. He investigates cellular interactions in the immune microenvironment, with particular attention to innate lymphoid cells (ILCs), neutrophils, and dendritic cells. His translational work includes novel vaccine platforms, epitranscriptomics, immune checkpoint modulation (e.g., CISH, PD-1), and cell therapy for diseases such as asthma, leukemia, and cancer. He also explores microbiome-immune crosstalk and inflammation-related organ damage (e.g., renal fibrosis, lung inflammation). His group has published extensively on m6A modifiers, microRNAs, and innovative delivery systems like gel-to-nanovaccines. His latest studies dive into immunometabolism and the interplay between immune cells and tissue repair, offering groundbreaking insights for future immunotherapies. Dr. Bae’s work is highly cited and remains at the forefront of immune system-based therapeutic innovation.

📚 Publications Top Notes:

  1. 📘 Therapeutic Potential of microRNA Against Th2-associated Immune Disorders – Current Topics in Medicinal Chemistry (2021)

  2. 💉 COVID-19 Vaccines and Oral-Mucosal Vector System as a Potential Vaccine Platform – Vaccines (2021)

  3. 🧬 Immunotherapeutic Potential of m6A-Modifiers and microRNAs in AML – Biomedicines (2021)

  4. 🎯 Epitranscriptomic Approach to Improve ICB Therapy by Targeting CISH – Cells (2021)

  5. 🧫 TFH-B-TRM Dysregulation and Anti-PD-1 Responses in EGFR-mutant Lung Cancer – Nature Communications (2021)

  6. 🧪 Adenoviral CD200R-Ig Enhances Antitumor Immunity via M2 Macrophage Inhibition – Molecular Therapy

  7. 🌫 Air Pollutant-induced Neutrophils Worsen Airway Inflammation – JACI (2021)

  8. 🦠 NCR+ILC3s and the Microbiome in Asthma Severity – Immune Network (2021)

  9. 📖 Advances in Personalized Therapy for AML by Targeting Intracellular Checkpoints – eBook Chapter (2021)

  10. 🧵 Siglec-F Neutrophils Drive Fibrosis in Renal Disease – JCI (2022)

🧾 Conclusion:

Dr. Yong-Soo Bae is an exceptional and highly deserving candidate for the Best Researcher Award. His contributions over four decades span foundational research, translational innovation, academic leadership, and scientific diplomacy. The depth of his scientific output, particularly in immunology, epigenetics, and vaccine development, is matched by his long-term commitment to mentoring, editorial work, and building research institutions in Korea.While enhancing his global recognition and expanding international collaborative outputs could further elevate his status, Dr. Bae’s consistent high-impact contributions, research leadership, and policy involvement clearly position him as a top-tier researcher in the life sciences.

Abbas Montayeri | Tissue Engineering Regeneration | Best Researcher Award

Published on by Cell Biologist

Assoc. Prof. Dr. Abbas Montayeri | Tissue Engineering Regeneration | Best Researcher Award

Assoc. Prof. Dr. Abbas Montayeri | K N Toosi University of Technology | Iran

Dr. Abbas Montazeri is an Associate Professor in the Faculty of Materials Science and Engineering at K.N. Toosi University of Technology, Tehran, Iran. With over a decade of academic and research experience, Dr. Montazeri specializes in molecular dynamics simulations, computational nanomechanics, and multiscale modeling. He received his Ph.D. in Nanotechnology from Sharif University of Technology, where he also completed his M.Sc. and B.Sc. in Mechanical Engineering. A resident researcher at IPM and director of graduate studies at KNTU, he has led pioneering work in biological nanocomposites, heat transfer at the nanoscale, and drug delivery systems. Dr. Montazeri’s contributions are widely recognized through numerous journal publications, a book chapter, and multiple national awards. His interdisciplinary work bridges fundamental simulation techniques and real-world applications, notably in advanced materials and biomedical engineering. He continues to mentor students and contribute actively to cutting-edge nanotechnology research.

Publication Profile:

Orcid

✅ Strengths for the Award:

  1. Outstanding Research Output: Dr. Montazeri has an impressive list of publications in top-tier international journals, demonstrating sustained and high-quality contributions to fields such as molecular dynamics, computational nanomechanics, and biomedical nanocomposites.

  2. Interdisciplinary Expertise: His research covers a diverse array of modern scientific domains, including drug delivery systems, nano-tribology, heat transfer at the nanoscale, and 2D nanostructures, highlighting his adaptability and scientific breadth.

  3. Innovative Methodologies: Use of MD simulations, data-driven modeling, and multiscale approaches showcases cutting-edge methodology with practical implications in biomedical engineering and materials science.

  4. Academic Leadership: Holding key positions such as Director of Graduate Studies and Vice-Chairman for Educational Affairs, he shows commitment not only to research but also to educational excellence and mentorship.

  5. National Recognition: Previous awards (e.g., Distinguished Young Researcher, Exceptional Talent Award) and top national ranks confirm his academic excellence and early recognition in the scientific community.

🛠️ Areas for Improvement:

  1. International Collaboration & Visibility: While publication quality is high, increased collaborations with international institutions could broaden the global impact and citation footprint.

  2. Patent or Industry Linkage: There’s no mention of technology transfer, industrial projects, or patents. Involving industry could enhance real-world application and innovation.

  3. Outreach & Public Engagement: Enhanced visibility through public lectures, conference keynote roles, or scientific community leadership would strengthen the public and academic profile.

🎓 Education:

Dr. Abbas Montazeri holds a distinguished academic record from Sharif University of Technology. He earned his Ph.D. in Nanotechnology/NanoMechanics from the Institute for Nano Science and Technology (2005–2010), where he focused on atomistic simulations and nanostructures. Before that, he completed his M.Sc. in Mechanical Engineering/Applied Design (2002–2004), working on solid mechanics and material behavior. His academic journey began with a B.Sc. in Mechanical Engineering/Solid Mechanics (1998–2002), during which he ranked 22nd nationally among nearly 250,000 candidates. His academic path reflects a steady progression into highly specialized research areas in nanomechanics and computational materials science. Throughout his education, Dr. Montazeri demonstrated academic excellence, receiving exceptional talent awards and high ranks in national entrance exams. His robust educational background laid the foundation for his interdisciplinary research in mechanical engineering, materials science, and biomedical applications.

💼 Professional Experience:

Dr. Montazeri has accumulated extensive professional experience in academia and research. He began his academic career as an Assistant Professor at K.N. Toosi University of Technology in 2012 and was promoted to Associate Professor in 2017. Concurrently, he has served in several administrative roles, including Vice-Chairman of Educational Affairs, Head of Divisions, and currently, Director of Graduate Studies at the Faculty of Materials Science and Engineering. Additionally, he has been a Resident Researcher at the School of Nano Science, IPM, since 2012. These roles reflect his leadership, commitment to education, and continuous contributions to nanotechnology research. His experience spans advanced computational modeling, educational management, and interdisciplinary collaboration. Dr. Montazeri has mentored numerous graduate students and has been instrumental in integrating simulation-based research with practical engineering applications, including drug delivery, tissue engineering, and nano-enabled sensors.

🏆 Awards and Honors:

Dr. Abbas Montazeri has received several prestigious awards that highlight his academic excellence and research contributions. In 2017, he was named a Distinguished Young Researcher at K.N. Toosi University of Technology. His Ph.D. thesis was selected as one of the best at the 7th Iranian Students Nanotechnology Conference in 2010. He was also honored with the Exceptional Talents Award by Sharif University’s Graduate Office in 2006. Early in his academic journey, Dr. Montazeri achieved remarkable ranks in competitive national exams: 20th place in the nationwide graduate entrance exam (2002) and 22nd place in Iran’s university entrance exam (1998) among hundreds of thousands of students. These accolades reflect a consistent pattern of high performance, innovation, and leadership in research and academia. His honors not only recognize past achievements but also underscore his ongoing contributions to materials science, computational mechanics, and nanotechnology.

🔬 Research Focus:

Dr. Montazeri’s research is at the forefront of computational materials science and nanotechnology. His work primarily involves Molecular Dynamics (MD) Simulation, NanoTribology, and Multiscale Modeling Techniques. He applies these methods to study biological nanocomposites for tissue engineering, heat transfer at the nanoscale, drug delivery systems, and 2D nanostructures. A strong focus of his research lies in understanding the mechanical, thermal, and interfacial behavior of materials at the atomic scale. His investigations into nanostructured composites, smart polymers, and surface-functionalized materials have opened new pathways in biomedical applications, especially in therapeutic implants and biosensors. He has also explored sintering processes, failure mechanisms, and data-driven modeling of nanomaterials. Dr. Montazeri’s interdisciplinary approach effectively bridges fundamental theoretical modeling with practical engineering challenges, making significant contributions to both academic literature and industrial innovation in advanced material systems.

📚 Publication Top Notes:

  • 🧪 Theoretical Modeling of CNT-Polymer Interactions – Elsevier Book Chapter (2017)

  • 💊 Molecular dynamics simulation reveals the reliability of Brij-58 nanomicellar drug delivery systems – J. Mol. Liquids, 2022

  • 🧱 Mechanical properties affected by coalescence mechanisms during Al-Cu nanoparticle sintering – Powder Tech, 2022

  • 🧩 Toughening role of surface-treated BN nanosheets in PLA nanocomposites – Eur. Polymer J., 2022

  • 🧪 Failure mechanisms in degraded hybrid composites via acoustic emission analysis – Eng. Failure Analysis, 2022

  • 🧬 Shape memory properties of graphene/polymer nanocomposites – Smart Mater. Struct., 2022

  • 🔬 Optimal sample location in quartz tuning fork biosensors – Biomedical Phys. Eng. Express, 2021

  • 🔥 Temperature-dependent sintering of metal nanoparticles – Powder Tech, 2021

  • 🧷 Adhesion in poly(L-lactic acid)/graphene nanocomposites via end-grafted polymers – Eur. Polymer J., 2021

  • 🌡️ Interfacial thermal conductance in functionalized BN/PLA nanocomposites – Prog. Organic Coatings, 2024

  • 📊 Predicting mechanical properties of defective h-BN nanosheets using data-driven models – Comput. Mater. Sci., 2023

  • ⚙️ Strain-rate plasticity of Ta-Cu nanocomposites for implants – Sci. Reports, 2023

  • 🦷 Mechanical properties of Ta/Cu nanocomposite dental implants – Metals and Mater. Int., 2023

  • 🧬 Neck growth and tensile properties in sintered Al-Cu systems via MD simulation – Adv. Powder Tech, 2023

🧾 Conclusion:

Dr. Abbas Montazeri is a highly qualified and deserving candidate for the Best Researcher Award. His rich research portfolio, technical depth, and consistent academic leadership position him as a leader in computational materials science and nanotechnology. While increasing international partnerships and industry engagement could further amplify his impact, his current accomplishments reflect a strong and balanced research profile that has significantly advanced both fundamental knowledge and applied science in nanomechanics and biomaterials.

Alla Mitrofanova | Lipid Signaling Biology | Best Researcher Award

Published on by Cell Biologist

Dr. Alla Mitrofanova | Lipid Signaling Biology | Best Researcher Award

Dr. Alla Mitrofanova | University of Miami | United States

Dr. Alla Mitrofanova is a Research Assistant Professor at the University of Miami Miller School of Medicine, specializing in the molecular and cellular mechanisms underlying kidney diseases. Holding dual citizenship in the United States and Russia, she has a robust international academic background and a solid reputation in nephrology research. Dr. Mitrofanova has significantly contributed to understanding podocyte biology and renal lipid metabolism. With a Ph.D. in Human Physiology and postdoctoral training in Molecular Biology, she has collaborated with leading scientists in the field and is a co-author of high-impact publications. Her academic journey reflects a blend of rigorous scientific training, innovation, and commitment to mentorship. A recognized member of various research consortia, she brings both clinical relevance and basic science rigor to her work, particularly in diabetic kidney disease and transplant nephrology. Her efforts position her as a strong candidate for the Best Researcher Award.

Publication Profile:

Scopus

✅ Strengths for the Award:

  1. 🔬 High-Impact Research Focus:

    • Strong emphasis on podocyte biology, diabetic kidney disease, and glomerular disorders, which are critical areas in nephrology research.

    • Research addresses fundamental disease mechanisms (lipid dysmetabolism, ER stress, pyroptosis), showing translational potential for therapy.

  2. 📚 Prolific and High-Quality Publications:

    • Authored/co-authored 10+ peer-reviewed articles in top-tier journals like Nature Reviews Nephrology, Kidney International, eLife, and Frontiers in Immunology.

    • Publications include commentaries, reviews, and original research, showcasing versatility.

  3. 🤝 Interdisciplinary and Collaborative Approach:

    • Works closely with globally recognized scientists such as Dr. Alessia Fornoni and Dr. George Burke.

    • Participates in cross-functional teams that bridge molecular science with clinical nephrology.

  4. 📈 Career Progression & Mentorship:

    • Rapid academic progression from Research Instructor to Research Assistant Professor.

    • Member of formal mentoring committees and contributes to the development of junior researchers.

  5. 📖 Author of Book Chapter:

    • Co-authored a chapter in Current Progress in Nephrology, reinforcing subject matter expertise.

🔄 Areas for Improvement:

  1. 💼 Independent Funding Leadership:

    • While research involvement is significant, leading grants as Principal Investigator (PI) would strengthen her portfolio and independence.

  2. 🌍 International Visibility:

    • Encouraged to expand international presence through invited lectures, keynote talks, and scientific panels.

  3. 🧭 Broader Research Footprint:

    • Future work could benefit from involvement in large-scale clinical trials, or application of findings to diverse patient populations.

  4. 🧪 Innovation in Techniques:

    • Introduction of new methods (e.g., single-cell omics, AI-driven histopathology) could further enhance impact.

📘 Education:

Dr. Mitrofanova completed her undergraduate degree in Biology (B.S., 2006) and a Master’s in Human Physiology (M.S., 2008) at Saint Petersburg State University, Russia. She earned her Ph.D. in Human Physiology in 2011 from the same institution, where she focused on cellular stress responses. To expand her expertise, she pursued postdoctoral training at the prestigious Schemyakin and Ovchinnikov Institute of Bioorganic Chemistry, focusing on Molecular Biology (2011–2013). This education provided her with interdisciplinary expertise spanning physiology, molecular biology, and disease pathophysiology. Her academic training integrates European rigor with international research exposure, laying a strong foundation for her scientific pursuits. Throughout her education, Dr. Mitrofanova has demonstrated excellence in both experimental design and translational relevance, which she continues to leverage in her current roles in the U.S.

🧪 Experience:

Dr. Mitrofanova currently serves as a Research Assistant Professor in the Department of Medicine at the University of Miami Miller School of Medicine. Since 2020, she has progressively advanced from a Research Instructor to her current rank, where she leads and contributes to multidisciplinary projects in nephrology. Her career began in academia and research institutions in Russia before transitioning to the U.S. She has worked closely with world-renowned mentors including Dr. Alessia Fornoni and Dr. George Burke. Her research has garnered substantial peer-reviewed publications, and she actively contributes to translational nephrology through collaborative and independent studies. Additionally, she plays a role in mentoring early-career researchers. Her deep involvement in both experimental and clinical nephrology research makes her a valuable asset to her department and a credible candidate for recognition in the scientific community.

🔬 Research Focus:

Dr. Mitrofanova’s research centers on the molecular mechanisms of chronic kidney diseases, particularly diabetic nephropathy and glomerular diseases. A primary area of focus is podocyte biology, including the roles of lipid metabolism, endoplasmic reticulum stress, and immune regulation in kidney pathology. Her work on SMPDL3b, ABCA1, and oxysterol-binding proteins has shed light on key pathways linking lipid dysregulation to proteinuria and CKD progression. She is also engaged in transplant nephrology, using transplantation models to study disease recurrence. Dr. Mitrofanova has been instrumental in decoupling proteinuria from CKD progression and identifying biomarkers and therapeutic targets. Her research bridges basic science with clinical application, aiming to identify precision therapies for kidney disease patients. The integration of advanced molecular biology tools and translational approaches highlights the innovative and impactful nature of her work in nephrology.

📚 Publications Top Notes:

  1. 🧬 SMPDL3b in Podocytes: Decoupling Proteinuria from CKD Progression in Experimental Alport Syndrome – Kidney International, 2025

  2. 🔬 Oxysterol-binding protein like 7 deficiency leads to ER stress-mediated apoptosis in podocytes and proteinuria – AJP Renal, 2024

  3. 🧠 Role of immune podocyte in glomerular diseases – Cells, 2024

  4. 🧫 Transplantation: platform to study recurrence of disease – Frontiers in Immunology, 2024

  5. 💡 The finer points of podocyte sphingolipid metabolism in diabetic kidney disease – Scientific Archives, 2023

  6. 💊 Management of Lupus Nephritis: New Treatment and Updated Guidelines – Kidney360, 2023

  7. 🔄 Renal lipid dysmetabolism in chronic kidney disease – Nature Reviews Nephrology, 2023

  8. 🧪 The podocyte: glomerular sentinel at the crossroads of innate and adaptive immunity – Frontiers in Immunology, 2023

  9. ⚙️ ABCA1 deficiency contributes to podocyte pyroptosis priming via APE1/IRF1 axis – Scientific Reports, 2023

  10. 🌿 Empagliflozin reduces renal lipotoxicity in experimental Alport syndrome – eLife, 2023

📝 Conclusion:

Dr. Alla Mitrofanova exhibits outstanding scientific productivity, depth in nephrology research, and a strong academic trajectory. Her contributions have significantly advanced our understanding of podocyte pathophysiology and kidney disease mechanisms. With continued focus on independent leadership and global engagement, she has the potential to emerge as a key innovator in the field.

Dagmar Schmid | Immunology Cellular Interactions | Women Researcher Award

Published on by Cell Biologist

Dr. Dagmar Schmid | Immunology Cellular Interactions | Women Researcher Award

Dr. Dagmar Schmid, HOCH, Health Ostschweiz, Kantonsspital St.Gallen, Klinik für Psychosomatik und Konsiliarpsychiatrie, Switzerland

PD Dr. med. Dagmar A. Schmid is a German physician and internationally recognized expert in psychosomatic medicine, consultative psychiatry, and sleep research. Born in Neuburg/Donau in 1969, she currently serves as Chief Physician and Director at the Clinic for Psychosomatics, Cantonal Hospital St. Gallen, Switzerland. With over two decades of experience across leading institutions in Germany and Switzerland, Dr. Schmid has made significant contributions to research on chronic pain, sleep disorders, stress, trauma, and Long COVID. Her integrative, evidence-based clinical approach bridges psychotherapy, neuroendocrinology, and psychosomatic care. She is also a passionate educator, holding lectureships at UZH, ETH, HSG, and USB, and is involved in curriculum development for medical training. A Fellow of the Max Planck Society, she holds a habilitation from the University of Zurich. Dr. Schmid combines research leadership, therapeutic innovation, and interdisciplinary collaboration, making her a compelling candidate for the Research for Women Researcher Award.

Publication Profile:

Scopus

✅ Strengths Supporting Suitability for the Award:

1. Outstanding Clinical-Scientific Integration

  • PD Dr. Schmid bridges psychiatry, psychosomatics, sleep medicine, and trauma, integrating clinical practice with impactful research.

  • Her work is deeply translational, evidenced by studies like CBT for narcolepsy, multimodal pain therapy, and psychotraumatology in somatic settings.

2. Highly Relevant and Timely Research Topics

  • Research on Long COVID, psychotraumatology, insomnia, and workplace mental health is at the forefront of global health challenges.

  • Interdisciplinary projects (e.g., with neurology, gynecology, immunology) reflect innovation and relevance to both women’s and public health.

3. International Recognition & Academic Output

  • Over 40 peer-reviewed publications, including in high-impact journals.

  • Multiple first-author papers, invited talks, and poster awards reflect peer validation.

  • Recipient of prestigious awards and fellowships (e.g., Max Planck Society, Heraeus Foundation).

4. Leadership and Mentorship

  • Clinic Director and Chief Physician since 2017.

  • Responsible for establishing therapy units and sleep diagnostics services.

  • Supervises dissertations, reflecting her mentorship commitment, especially valuable for empowering future women researchers.

5. Teaching & Outreach

  • Teaching roles at major Swiss institutions (ETH, UZH, HSG, USB).

  • Leadership in educational modules on psychosomatics, communication, and sleep disorders.

  • Speaker in national specialist curricula, enhancing knowledge dissemination.

6. Focus on Women’s Health

  • Specific projects on gynecological trauma, psychosomatics in oncology, and stress-related conditions affecting women’s mental and physical health.

⚠️ Areas for Potential Improvement or Future Growth:

1. International Visibility in Gender-Specific Medicine

  • While her research is highly relevant to women’s mental health, more direct engagement in gender-specific medical research networks or global women’s health collaborations would further strengthen her candidacy.

2. Research Leadership in Consortia

  • Leading international multicenter studies or EU-funded programs would enhance her influence on policy-level decisions in women’s mental health.

3. Visibility in Advocacy and Policy

  • Greater participation in public policy or healthcare advisory roles (e.g., for WHO or national bodies) on topics like Long COVID in women or trauma-informed care would expand her societal impact.

🎓 Education:

Dr. Schmid earned her medical doctorate at the Max Planck Institute of Psychiatry, Munich, with a dissertation on hormone secretion and sleep EEG in depression. From 1998 to 2002, she held a prestigious scholarship from the Max Planck Society, further advancing her research in psychoneuroendocrinology. Her habilitation (postdoctoral qualification) was completed at the University of Zurich in 2023, titled “Psychophysiology in Psychosomatics Using Sleep as an Example”. She is a certified specialist in psychiatry and psychotherapy in both Germany and Switzerland. Her therapeutic training includes Cognitive Behavioral Therapy (CBT), Dialectical Behavioral Therapy (DBT), Interpersonal Psychotherapy (IPT), EMDR trauma therapy, hypnotherapy, and CBASP for chronic depression. Dr. Schmid has also completed the GCP clinical research certification, the SIM expert certificate, and advanced training in psycho-oncology. Her interdisciplinary education forms the foundation of her clinical innovation and scientific impact.

💼 Professional Experience:

Dr. Schmid has held senior positions in top psychiatric and psychosomatic institutions. From 1998–2002, she worked at the Max Planck Institute, followed by clinical roles in Zurich and Basel. At Clienia Schlössli AG, she led psychotherapy and DBT programs, later joining the University Hospital Zurich, working in sleep medicine, liaison psychiatry, and emergency psychiatry. Since 2017, she is Chief Physician and Clinic Director for Psychosomatics and Consultant Psychiatry at the Cantonal Hospital St. Gallen, where she also established a sleep diagnostics department. She’s active in training and supervising medical staff, conducting expert evaluations, and coordinating interdisciplinary care for Long COVID, trauma, and chronic pain. Since 2025, she has also been affiliated with the University Hospital Basel. Her professional journey reflects leadership in clinical development, patient-centered innovations, and academic collaboration.

🏆 Awards & Honors:

Dr. Schmid’s excellence in research and clinical work has been recognized with multiple awards. She received the prestigious Max Planck Society Fellowship (1998–2001) and the Heraeus Foundation Award in 2000. She has won poster prizes at national congresses for work in psychotraumatology (SAPPM/SPS 2022) and sleep-pain therapy (SGPP 2022). She holds the Certificate of Competence in Sleep Medicine, Psycho-Oncology, and is a certified CBT/DBT/IPT/EMDR therapist. She’s a frequent speaker in consultant psychiatry and psychosomatics curricula across Switzerland and Germany, and has led training programs for medical communication, CBT-insomnia, and trauma therapy. Her habilitation (2023) and over 40 peer-reviewed publications reflect sustained academic achievement. Additionally, she has supervised doctoral and master’s theses and collaborated in major clinical research projects, including Long COVID, narcolepsy, and psychosomatic gynecology. These honors and contributions underscore her qualification for the Research for Women Researcher Award.

🔬 Research Focus:

Dr. Schmid’s research bridges psychosomatic medicine, neuroendocrinology, and sleep science, with emphasis on chronic pain, trauma, stress disorders, and Long COVID. Her work explores how hormonal rhythms, sleep patterns, and mental health interact—using sleep EEG, endocrine markers, and clinical interventions. She developed novel group therapies for narcolepsy, dizziness, and insomnia and led outcome evaluations for interdisciplinary multimodal pain therapy (IMPT). Her recent focus includes psychosocial recovery in healthcare workers post-COVID, and pilot studies on plasmapheresis in chronic fatigue syndrome. She also investigates cognitive outcomes, emotion regulation, and therapeutic online models, especially for vulnerable populations. Her research integrates clinical trials, neurobiology, and psychotherapy, contributing to evidence-based advancements in psychosomatic practice. She leads projects at the Cantonal Hospital St. Gallen and collaborates with researchers across neurology, gynecology, and internal medicine, making her research highly interdisciplinary and translational in nature.

📚 Publications Top Notes:

  • 🧠 Increased GH Response to Apomorphine in Parkinson vs MSA (Arch Neurol, 2001)

  • 🍔 Ghrelin Stimulates Appetite, GH, ACTH, Cortisol in Normals (Sleep Res, 2005)

  • 🛌 Nocturnal Ghrelin Levels & Sleep EEG Correlation (Psychoneuroendocrinology, 2006)

  • 🌙 CRH1-Antagonist Improves Sleep EEG in Depression (J Psychiatr Res, 2004)

  • 🌀 Dizziness and Anxiety – A Psychosomatic Link (Health Qual Life Outcomes, 2020)

  • 😴 Ghrelin Promotes Deep Sleep in Humans (AJPEM, 2003)

  • 🧬 CRH Test, Sleep, and Depression Vulnerability (J Psychiatr Res, 2008)

  • 🧪 Cortisol and Sleep Depth in Depression (J Psychiatr Res, 2008)

  • 🦠 HPA Axis & Cytokines in Depression (J Psychiatr Res, 2003)

  • 🧬 Factors Affecting HPA Reactivity in Depression (Neuropsychopharmacology, 2003)

  • 🧘‍♀️ Long COVID & Mental Health in Healthcare Workers (In Prep, 2025)

  • 🛏 IMPT Effectiveness in Chronic Pain-Related Insomnia (In Progress)

  • 🎯 Group Therapy in Narcolepsy: Emotion Regulation & Acceptance (2021-2022)

  • 🎓 CBT-Insomnia Education for Non-Psychiatrists (Ongoing Teaching)

✅ Conclusion:

PD Dr. med. Dagmar A. Schmid is an exceptionally qualified and impactful candidate for the Research for Women Researcher Award. Her integrative, patient-centered research, particularly in sleep medicine, psychotraumatology, and Long COVID, directly contributes to improving women’s health. Combined with her extensive clinical leadership, educational outreach, and publication record, she exemplifies the spirit of this award.